Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Cyclacel Pharmaceuticals, Inc. | c14674e10vk.htm |
| EX-21 - EXHIBIT 21 - Cyclacel Pharmaceuticals, Inc. | c14674exv21.htm |
| EX-3.2 - EXHIBIT 3.2 - Cyclacel Pharmaceuticals, Inc. | c14674exv3w2.htm |
| EX-23.1 - EXHIBIT 23.1 - Cyclacel Pharmaceuticals, Inc. | c14674exv23w1.htm |
| EX-31.1 - EXHIBIT 31.1 - Cyclacel Pharmaceuticals, Inc. | c14674exv31w1.htm |
| EX-31.2 - EXHIBIT 31.2 - Cyclacel Pharmaceuticals, Inc. | c14674exv31w2.htm |
| EX-32.1 - EXHIBIT 32.1 - Cyclacel Pharmaceuticals, Inc. | c14674exv32w1.htm |
| EX-10.14 - EXHIBIT 10.14 - Cyclacel Pharmaceuticals, Inc. | c14674exv10w14.htm |
| EX-10.13 - EXHIBIT 10.13 - Cyclacel Pharmaceuticals, Inc. | c14674exv10w13.htm |
Exhibit 32.2
CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. s 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the
undersigned officer of Cyclacel Pharmaceuticals, Inc. ( the “Company”) hereby certifies, to such
officer’s knowledge, that:
| (i) | the Annual Report on Form 10-K of the Company for the year ended December 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
| (ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 31, 2011
|
/s/ Paul McBarron
|
|||
| Chief Operating Officer, Chief Financial Officer | ||||
| and Executive Vice President, Finance |